DSCSA Implementation: Insights From Manufacturers and Distributors

Survey Reveals New Trends in Serialization Strategies, Perceptions and Exceptions

Enforcement is here. Is your DSCSA strategy built to last?

Drug Supply Chain Security Act (DSCSA) enforcement is now in full effect, and many manufacturers and distributors are now feeling the full weight of serialized compliance in day-to-day operations.

A new survey of pharmaceutical executives reveals high levels of confidence in their DSCSA implementation — but rising exception volumes, architectural gaps and operational risks may signal overconfidence in compliance readiness.

Download the full survey report to understand how your peers are navigating serialization, exceptions and warehouse system limitations — and what these trends mean for your operation. 

Download the full report

What’s inside the report

Based on a 2025 survey of 100 pharmaceutical executives (director level and above), this research explores:

  • The frequency and operational impact of DSCSA exceptions

  • Gaps in proactive and reactive exception management

  • The role of the WMS in preventing downstream compliance risk

AdobeStock_844023197 4
Pharmacy-survey-1200x1200

What’s inside the report

visibility-connections

Operational impact

The frequency and operational impact of DSCSA exceptions 

distribution-icon

Exception management

Gaps in proactive and reactive exception management
ai-brain

Compliance risk

The role of the WMS in preventing downstream compliance risk

About the survey

This research is based on an online survey conducted by BioPharma Dive in October and November 2025. 

100 executives across operations, warehousing, compliance, supply chain and IT participated in the study. The sample was generated from BioPharma Dive databases. 

About the survey

This research is based on an online survey conducted by BioPharma Dive in October and November 2025. 100 executives across operations, warehousing, compliance, supply chain and IT participated in the study. The sample was generated from BioPharma Dive databases.